Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,350 | 64 | 91.2% |
| Education | $130.60 | 4 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $297.58 | 10 | $0 (2021) |
| Astellas Pharma US Inc | $178.82 | 6 | $0 (2024) |
| Organon Llc | $158.98 | 6 | $0 (2024) |
| Exeltis, USA Inc. | $111.13 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $94.04 | 4 | $0 (2021) |
| TherapeuticsMD, Inc. | $81.12 | 4 | $0 (2021) |
| MAYNE PHARMA INC. | $73.06 | 4 | $0 (2022) |
| CooperSurgical, Inc. | $71.50 | 3 | $0 (2021) |
| MAYNE PHARMA COMMERCIAL LLC | $68.71 | 5 | $0 (2024) |
| MILLICENT US INC | $55.39 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.62 | 15 | MAYNE PHARMA COMMERCIAL LLC ($68.71) |
| 2023 | $101.83 | 5 | Exeltis, USA Inc. ($34.51) |
| 2022 | $293.90 | 10 | Organon LLC ($131.47) |
| 2021 | $310.36 | 16 | AbbVie Inc. ($85.32) |
| 2020 | $211.70 | 12 | Daiichi Sankyo Inc. ($67.06) |
| 2019 | $304.66 | 10 | AbbVie, Inc. ($173.11) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.49 | General |
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena, Skyla | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Womens Health | ||||||
| 09/03/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.45 | General |
| 08/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.74 | General |
| 07/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $9.11 | General |
| 06/18/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 06/05/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $27.51 | General |
| 05/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Biological | ||||||
| 04/04/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Biological | ||||||
| 02/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/07/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: VACCINES | ||||||
| 01/27/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.92 | General |
| 01/04/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Urology | ||||||
| 11/15/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Biological | ||||||
| 10/25/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oral Contraceptive | ||||||
| 07/18/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: VACCINE | ||||||
| 06/07/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Oral Contraceptive | ||||||
| 03/15/2023 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Surgical | ||||||
| 12/08/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.95 | General |
| 11/22/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $21.56 | General |
| 11/15/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: ETONOGESTREL | ||||||
| 11/15/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: ETONOGESTREL | ||||||
| 11/15/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: ETONOGESTREL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 544 | 568 | $137,743 | $34,561 |
| 2022 | 7 | 288 | 302 | $68,762 | $19,026 |
| 2021 | 5 | 193 | 207 | $29,045 | $11,139 |
| 2020 | 4 | 125 | 136 | $17,460 | $6,377 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 169 | 169 | $21,125 | $7,044 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 76 | $29,944 | $6,278 | 21.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 131 | 131 | $17,292 | $5,812 | 33.6% |
| 77067 | Screening mammography | Office | 2023 | 27 | 27 | $14,310 | $3,567 | 24.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 29 | 29 | $11,078 | $2,488 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 48 | $13,344 | $2,412 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,710 | $2,386 | 22.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 24 | 25 | $8,450 | $2,105 | 24.9% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 27 | 27 | $6,750 | $1,479 | 21.9% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 15 | 15 | $4,740 | $990.15 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 50 | $19,700 | $4,953 | 25.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 95 | 95 | $11,875 | $3,979 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 49 | $13,622 | $3,208 | 23.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 64 | 64 | $8,448 | $2,844 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,670 | $2,365 | 27.3% |
| 56605 | Biopsy of growth of external female genitals, first growth | Office | 2022 | 14 | 15 | $4,395 | $1,254 | 28.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 12 | $2,052 | $423.14 | 20.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 54 | $8,100 | $3,653 | 45.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 59 | 59 | $7,375 | $2,454 | 33.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $5,750 | $2,177 | 37.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 46 | 46 | $5,060 | $2,079 | 41.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 23 | $2,760 | $775.90 | 28.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 42 | $6,300 | $2,465 | 39.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 38 | 38 | $4,750 | $1,642 | 34.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 31 | 31 | $3,410 | $1,384 | 40.6% |
About Dr. Rosana Salama Bello, M.D
Dr. Rosana Salama Bello, M.D is a Obstetrics & Gynecology healthcare provider based in Vero Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1376958496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rosana Salama Bello, M.D has received a total of $1,481 in payments from pharmaceutical and medical device companies, with $258.62 received in 2024. These payments were reported across 68 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,350).
As a Medicare-enrolled provider, Salama Bello has provided services to 1,150 Medicare beneficiaries, totaling 1,213 services with total Medicare billing of $71,104. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Vero Beach, FL
- Active Since 06/26/2014
- Last Updated 07/10/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1376958496
Products in Payments
- Orilissa (Drug) $173.11
- NEXPLANON (Drug) $113.12
- SLYND (Drug) $111.13
- LO LOESTRIN FE (Drug) $108.44
- INJECTAFER (Drug) $94.04
- Veozah (Drug) $59.78
- Uterine Manipulators & Injectors (Device) $44.20
- ANNOVERA (Drug) $43.06
- IMVEXXY (Drug) $38.06
- INTRAROSA (Drug) $37.36
- Femring (Drug) $35.48
- Myrbetriq (Drug) $33.09
- Other Gyn Products (Device) $27.30
- Phexxi (Drug) $24.77
- PREVENA (Device) $24.50
- ACESSA PROVU SYSTEM (Device) $22.71
- Kyleena (Drug) $22.63
- Mirena (Drug) $22.38
- GARDASIL 9 (Biological) $21.48
- Myosure (Device) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Vero Beach
Dr. Kristy Crawford, D.o, D.O
Obstetrics & Gynecology — Payments: $40,400
Dr. Lindsey Bruce, M.d, M.D
Obstetrics & Gynecology — Payments: $4,410
Brandi Wilson, Md, MD
Obstetrics & Gynecology — Payments: $3,554
Deni Malave-Huertas, Md, MD
Obstetrics & Gynecology — Payments: $1,146
Dr. Marina Moore, Md, MD
Obstetrics & Gynecology — Payments: $535.17
Dr. Cristina Mcclure, D.o, D.O
Obstetrics & Gynecology — Payments: $456.94